gip and glp 1 drugs Science Behind Glucagon Receptor Agonists for Obesity Research | News & Announcements The GLP-1 Agonists and Obesity:

Umpiperrez, J

In obesity care, the benefits are framed more broadly, encompassing improvements in mobility, sleep, metabolic health, and overall well-being

Effects of GLP1RAs on pregnancy rate and menstrual cyclicity in women with polycystic ovary syndrome: a meta-analysis and systematic review

doi: 10.3892/or.2015.4476 218 HeWYuSWangLHeMCaoXLiYet al

Patient-reported outcomes following treatment with the human GLP-1 analogue liraglutide or glimepiride in monotherapy: results from a randomized controlled trial in patients with type 2 diabetes

Looking toward the future, one has only to look at www.ClincalTrials.gov to see the many studies underway and planned for these drugs